MAOA and Parkinson disease: Selective inhibition of MAO-A, which specifically metabolizes serotonin, norepinephrine, and tyramine is effective in the depression treatment, while selective inhibition of MAO-B, which specifically degrades dopamine, is effective in the treatment of Parkinson’s disease (PD) [5,6].